Connect with us

Savella (milnacipran)


Milnacipran (or SAVELLA, IXEL®) is mainly prescribed to treat fibromyalgia.

Status: ACTIVE

Class: Serotonin-norepinephrine reuptake inhibitor (SNRI)

FDA Approval: 2008

Dosage Forms: 12.5 mg, 25 mg, 50 mg, 100 mg

Biological Half-life: 8 hours

Side Effects: Dizziness, dry mouth, nausea, headache, constipation, insomnia, hot flush, hyperhidrosis, vomiting, tachycardia, hypertension, sexual dysfunction, increased suicide risk

Routes of Administration: Oral

Pregnancy Category: C (US)

  www.savella.com

Like Us

Advertisement
Advertisement